Health Trials

Postbariatric Hypoglycemia

2

Review clinical trials related to Postbariatric Hypoglycemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglycemia

VGX-001-013 (EMERGE) is a Phase 2b study to evaluate an investigational new drug, mizagliflozin, for safety, tolerability and its ability to prevent low blood sugar in patients with post-bariatric hypoglycemia.

Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Vogenx, Inc.Updated: Aug 12, 2026
Eligibility criteria

Males and nonpregnant females, ages ≥18 years old, having had Roux-en-Y bariatri... [+4]

History of current medical conditions excluding PBH which may result in hypoglyc... [+13]

Read more
Status: Recruiting

Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?

The goal of this observational study is to learn about how bariatric surgery affects the metabolism of cortisol. The main question it aims to answer is whether changes in cortisol contribute to the development of reactive hypoglycemia? 100 individuals who have previously undergone bariatric surgery, are planned to be included.

Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: Esbjerg Hospital - University Hospital of Southern DenmarkUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Roux-en-Y gastric bypass [+1]

Pregnancy and breastfeeding [+7]

Read more